Inhibition by selenium of intrahepatic cholangiocarcinoma induction in Syrian golden hamsters by N'-nitrosobis(2-oxopropyl)amine. 1991

Y Kise, and M Yamamura, and M Kogata, and M Nakagawa, and S Uetsuji, and H Takada, and K Hioki, and M Yamamoto
Department of Surgery, Kansai Medical University, Osaka, Japan.

The effects of selenium supplementation on induction of cholangiocarcinomas and related precancerous lesions in female Syrian Golden hamsters by N'-nitrosobis(2-oxopropyl)amine (BOP) were investigated. Four-week-old animals were divided into two groups according to the selenium level contained in the drinking water (0.1 ppm or 4.0 ppm) and fed a purified diet containing less than 0.05 ppm of the trace element. Starting at Week 4 of the experiment, hamsters were administered 10 weekly injections of BOP (10 mg/kg body wt) and then killed 18 weeks after the last carcinogen administration. Animals receiving physiological saline alone served as controls. Cholangiocellular carcinomas tended to be reduced, and putative preneoplastic lesions of cholangiofibrosis were significantly decreased in the high-as opposed to the low-selenium groups in terms of both incidence rate and number per effective animal. The respective high and low selenium values for incidence and number were 24/38% and 0.34/0.66, respectively, for cholangiocarcinomas and 50/89% and 1.21/8.44, respectively, for cholangiofibroses. Proliferation of intrahepatic bile ducts was also significantly inhibited in the high-selenium group along with cyst formation. Biochemical investigation revealed both selenium level and glutathione peroxidase activity to be significantly greater in the high-than in the low-selenium group livers. The results thus suggest that selenium may inhibit BOP-induction of bile duct lesions, possibly via glutathione peroxidase-mediated alteration of carcinogenesis.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008647 Mesocricetus A genus in the order Rodentia and family Cricetidae. One species, Mesocricetus auratus or golden hamster is widely used in biomedical research. Hamsters, Golden,Hamsters, Golden Syrian,Hamsters, Syrian,Mesocricetus auratus,Syrian Golden Hamster,Syrian Hamster,Golden Hamster,Golden Hamster, Syrian,Golden Hamsters,Golden Syrian Hamsters,Hamster, Golden,Hamster, Syrian,Hamster, Syrian Golden,Syrian Hamsters
D009602 Nitrosamines A class of compounds that contain a -NH2 and a -NO radical. Many members of this group have carcinogenic and mutagenic properties. Nitrosamine
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002759 Adenoma, Bile Duct A benign tumor of the intrahepatic bile ducts. Cholangioma,Adenomas, Bile Duct,Bile Duct Adenoma,Bile Duct Adenomas,Cholangiomas
D005260 Female Females
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012643 Selenium An element with the atomic symbol Se, atomic number 34, and atomic weight 78.97. It is an essential micronutrient for mammals and other animals but is toxic in large amounts. Selenium protects intracellular structures against oxidative damage. It is an essential component of GLUTATHIONE PEROXIDASE. Selenium-80,Selenium 80
D016588 Anticarcinogenic Agents Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. Anti-Carcinogenic Agents,Anti-Carcinogenic Drugs,Anti-Carcinogenic Effect,Anti-Carcinogenic Effects,Anticarcinogenic Drugs,Anticarcinogenic Effect,Anticarcinogenic Effects,Anticarcinogens,Agents, Anti-Carcinogenic,Agents, Anticarcinogenic,Anti Carcinogenic Agents,Anti Carcinogenic Drugs,Anti Carcinogenic Effect,Anti Carcinogenic Effects,Drugs, Anti-Carcinogenic,Drugs, Anticarcinogenic,Effect, Anti-Carcinogenic,Effect, Anticarcinogenic,Effects, Anti-Carcinogenic,Effects, Anticarcinogenic

Related Publications

Y Kise, and M Yamamura, and M Kogata, and M Nakagawa, and S Uetsuji, and H Takada, and K Hioki, and M Yamamoto
June 1978, Cancer letters,
Y Kise, and M Yamamura, and M Kogata, and M Nakagawa, and S Uetsuji, and H Takada, and K Hioki, and M Yamamoto
June 1983, Journal of the National Cancer Institute,
Y Kise, and M Yamamura, and M Kogata, and M Nakagawa, and S Uetsuji, and H Takada, and K Hioki, and M Yamamoto
January 1990, Acta morphologica Hungarica,
Y Kise, and M Yamamura, and M Kogata, and M Nakagawa, and S Uetsuji, and H Takada, and K Hioki, and M Yamamoto
May 1977, Journal of the National Cancer Institute,
Y Kise, and M Yamamura, and M Kogata, and M Nakagawa, and S Uetsuji, and H Takada, and K Hioki, and M Yamamoto
July 2012, Pancreas,
Y Kise, and M Yamamura, and M Kogata, and M Nakagawa, and S Uetsuji, and H Takada, and K Hioki, and M Yamamoto
August 1980, Cancer letters,
Y Kise, and M Yamamura, and M Kogata, and M Nakagawa, and S Uetsuji, and H Takada, and K Hioki, and M Yamamoto
April 1994, Cancer letters,
Y Kise, and M Yamamura, and M Kogata, and M Nakagawa, and S Uetsuji, and H Takada, and K Hioki, and M Yamamoto
March 1984, Journal of the National Cancer Institute,
Y Kise, and M Yamamura, and M Kogata, and M Nakagawa, and S Uetsuji, and H Takada, and K Hioki, and M Yamamoto
February 1982, Chemico-biological interactions,
Y Kise, and M Yamamura, and M Kogata, and M Nakagawa, and S Uetsuji, and H Takada, and K Hioki, and M Yamamoto
July 1991, Carcinogenesis,
Copied contents to your clipboard!